Abstract
In vivoand in vitroperformances of a rectally applied osmotic delivery system containing a water-soluble derivative of theophylline were compared. The system was applied in six healthy volunteers during 72 h, and a comparison was made with two conventional dosage forms, a suppository and a solution administered orally, given once. In vitro,a perfect zero-order release rate with the osmotic system was obtained. In all subjects, application of the osmotic system resulted in a constant steady-state theophylline level just as in a long time zero-order i.v. infusion, which strongly suggests that the release rate in vivois zero-order too. The release rate was not influenced by renewing the dosage form after 36 hr or by defecation. The in vivoand in vitrorelease rates were almost identical and subjectindependent.
Similar content being viewed by others
References
J. Urquhart (ed).Controlled Release Pharmaceuticals. American Pharmaceutical Association, Washington, D.C., 1981.
F. Theeuwes. Elementary osmotic pump.J. Pharm. Sci. 64:1987–1991 (1975).
A. Zaffaroni. Therapeutic system: the key to rational drug therapy.Drug Metab. Rev. 8:191–221 (1978).
L. G. J. de Leede, A. G. de Boer, and D. D. Breimer. Rectal infusion of the model drug antipyrine with an osmotic delivery system.Biopharm. Drug. Dispos. 2:131–136 (1981).
A. G. de Boer, D. D. Breimer, H. Mattie, J. Pronk, and J. M. Gubbens-Stibbe. Rectal bioavailability of lidocaine in man: partial avoidance of ldfirst-passrd metabolism,Clin. Pharmacol Ther. 26:701–709 (1979).
A. G. de Boer, F. Moolenaar, L. G. J. de Leede, and D. D. Breimer. The rectal route in clinical pharmacokinetics.Clin. Pharmacokin., in press.
R. A. Upton, J. F. Thiercelin, T. W. Guentert, L. Sansom, J. R. Powell, P. E. Coates, and S. Riegelman. Evaluation of the absorption from some commercial sustained release theophylline products.J. Pharmacokin. Biopharm. 8:130–149 (1980).
F. Theeuwes and S. I. Yum. Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations.Ann. Biomed. Eng. 4:343–353 (1976).
M. Danhof, B. M. J. Loomans, and D. D. Breimer. Bepaling van theophylline in plasma en speeksel i.a.v. coffeinemetabolieten.Pharm. Weekbl. 113:672–676 (1978).
S. Sved and D. L. Wilson. Simultaneous assay of the methylxanthine metabolites of caffeine in plasma by HPLC.Res. Commun. Chem. Pathol. Pharmacol. 17:319–331 (1977).
A. G. de Boer and D. D. Breimer. Rapid and sensitive gas Chromatographic determination of underivatized theophylline in plasma and saliva.Pharm. Weekbl. 112:764–767 (1977).
S. Sved, R. D. Hossie, and I. J. McGilveray. The human metabolism of caffeine to theophylline.Res. Commun. Pathol. Pharmacol. 13:185–192 (1976).
W. L. Chiou. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma-level-time curve.J. Pharmacokin. Biopharm. 6:539–547 (1978).
R. Süverkrüp. Discontinuous absorption processes in pharmacokinetic models.J. Pharm. Sci. 68:1395–1400 (1979).
S. P. Galant, S. A. Gillman, L. H. Cummins, P. P. Kozak, and J. J. Orcutt. Reliability of salivary theophylline as a guide to plasma theophylline levels.Am. J. Dis. Child. 131:970–972 (1977).
C. J. de Blaey and A. G. de Boer. Kwaliteitsbeheersing van aminophylline zetpillen.Pharm. Weekbl. 111:1216–1221 (1976).
J. J. Tukker, J. P. Crombeen, D. D. Breimer and C. J. de Blaey. The bioavailability of seven commercially available rectal aminophylline suppositories.Pharm. Weekbl. Sci. Ed. 3:221–231 (1981).
T. B. Tjandramaga, R. Verbesselt, A. van Hecken, and P. J. de Schepper. Comparative systemic availability of rectal and oral preparations of microcrystalline theophylline.Curr. Med. Res. Opin. 6 (S6): 142–150 (1979).
P. A. Nell, M. Schwartz, and R. J. Greene. Comparison of i.v. and rectal aminophylline in the acutely ill asthmatic child.J. Allergy Clin. Immunol. 61:174 (1978).
P. Bolme, P. O. Edlund, M. Eriksson, L. Paalzow, and B. Winbladh. Pharmacokinetics of theophylline in young children with asthma: comparison of rectal enema and suppository.Eur. J. Clin. Pharmacol. 16:133–139 (1979).
L. Hendeles, M. Weinberger, and L. Bighley. Absolute bioavailability of oral theophylline.Am. J. Hasp. Pharm. 34:525–527 (1977).
L. J. Lesko, A. T. Canada, G. Eastwood, D. Walker, and D. R. Brousseau. Pharmacokinetics and relative bioavailability of oral theophylline capsules.J. Pharm. Sci. 68:1392–1394 (1979).
R. A. Upton, L. Sansom, T. W. Guentert, J. R. Powell, J. F. Thiercellin, V. P. Shah, P. E. Coates, and S. Riegelman. Evaluation of the absorption of 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria.J. Pharmacokin. Biopharm. 8:229–242 (1980).
T. N. Tozer, D. D. S. Tang-liu, and S. Riegelman. Linear versus nonlinear pharmacokinetics. InTopics in Pharmaceutical Sciences, D. D. Breimer and P. Speiser (eds.), Elsevier/North-Holland Biomedical Press, Amsterdam, 1982, pp. 3–17.
Author information
Authors and Affiliations
Additional information
This investigation was supported in part by a grant from the Dr. Saal van Zwanenberg Stichting (Oss, The Netherlands) and the ALZA Corporation (Palo Alto, Calif.).
Rights and permissions
About this article
Cite this article
de Leede, L.G.J., de Boer, A.G., van Velzen, S.L. et al. Zero-order rectal delivery of theophylline in man with an osmotic system. Journal of Pharmacokinetics and Biopharmaceutics 10, 525–537 (1982). https://doi.org/10.1007/BF01059035
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01059035